Učitavanje...
Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
BACKGROUND: Favipiravir possesses high utility for treating patients with COVID-19. However, research examining the efficacy and safety of favipiravir for patients with COVID-19 is limited. METHODS: We conducted a systematic review of published studies reporting the efficacy of favipiravir against C...
Spremljeno u:
| Izdano u: | BMC Infect Dis |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8159019/ https://ncbi.nlm.nih.gov/pubmed/34044777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-06164-x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|